Treatment News : Global HIV Treatment Reaches Tipping Point in Many Nations

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » October 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

October 9, 2013

Global HIV Treatment Reaches Tipping Point in Many Nations

Many of the countries with the greatest HIV epidemics are now in a sense winning the war against the disease, according to The New York Times. AVAC, the HIV treatment and prevention advocacy group, has conducted an analysis comparing the ratio of new infections in a particular country or region to the increase in people on antiretrovirals (ARVs). If a country begins to put more people on therapy than are newly infected, a crucial “tipping point” is reached.

The world on a whole is slightly below reaching this tipping point, dragged down by the hard-hit nations of Nigeria, Mozambique, the Democratic Republic of Congo, Lesotho, India, Burundi and Kenya. Nigeria’s epidemic is by far the most challenged, with more than four new infections for every one person put on ARVs. Sub-Saharan Africa’s ratio is actually better than the globe’s at large; the region is only a hair below the tipping point.

Meanwhile, those nations considered winners in the fight against HIV include Rwanda, Botswana, Zimbabwe, South Africa, Ethiopia and Haiti, among others.

AVAC stresses that it is possible for countries to slip back into losing territory. On an informational poster, the agency writes: “That’s why it is essential to achieve optimal coverage rates of high-impact prevention including voluntary medical male circumcision, male and female condoms and harm reduction. Newer strategies such as PrEP [pre-exposure prophylaxis] and, eventually, a microbicide or vaccine should also be used for maximum impact.”

To read a POZ feature on circumcision as HIV prevention, click here.

To read the Times story, click here.

To read the AVAC poster, click here.

Search: HIV, tipping point, ratio, AVAC, treatment, antiretrovirals, new infections, The New York Times, voluntary medical male circumcision.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Should the U.S. gay blood ban end?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.